# FDA recall D-0573-2022

> **RISING PHARMACEUTICALS** · Class II · drug recall initiated 2022-02-07.

## Product

Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01

## Reason for recall

Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0573-2022
- **Recalling firm:** RISING PHARMACEUTICALS
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2022-02-07
- **Report date:** 2022-03-02

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** East Brunswick, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0573-2022

## Citation

> AI Analytics. FDA recall D-0573-2022. Retrieved 2026-06-10 from https://api.ai-analytics.org/recall/D-0573-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*